![Sharon Shacham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sharon Shacham
Direktor/Vorstandsmitglied bei
ACRIVON THERAPEUTICS, INC.
Vermögen: 14 986 $ am 31.05.2026
Profil
Sharon Shacham was the founder of Karyopharm Therapeutics, Inc., founded in 2008, and held the titles of President & Chief Scientific Officer from 2015 to 2021.
Current jobs include Director at Nasus Pharma Ltd. starting in 2025 and Independent Director at Acrivon Therapeutics, Inc. starting in 2020.
Former jobs include Director-Algorithm & Software Development at Predix Pharmaceuticals, Inc. and Senior Vice President-Drug Development at EPIX Pharmaceuticals, Inc. from 2000 to 2009.
Education includes undergraduate, MBA, and doctorate degrees from Tel-Aviv University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.05.2026 | 9 366 ( 0,02 % ) | 14 986 $ | 31.05.2026 | |
NASUS PHARMA LTD. -.--% | 25.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Sharon Shacham
| Unternehmen | Position | Beginn |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.10.2020 |
| NASUS PHARMA LTD. | Direktor/Vorstandsmitglied | 11.08.2025 |
Ehemalige bekannte Positionen von Sharon Shacham
| Unternehmen | Position | Ende |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Gründer | 03.05.2021 |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Corporate Officer/Principal | 01.04.2009 |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Corporate Officer/Principal | - |
Ausbildung von Sharon Shacham
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Nasus Pharma Ltd.
 Nasus Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops powder-based intranasal products | Health Technology |
